CARCINOID TUMOUR OF THE GASTROINTESTINAL TRACT

This adverse event was reported 119 times

These drugs are most commonly taken by patients reporting CARCINOID TUMOUR OF THE GASTROINTESTINAL TRACT:

# Drug Count
0 LISINOPRIL 14
1 OCTREOTIDE ACETATE 13
2 METHOTREXATE SODIUM 10
3 METOPROLOL TARTRATE 10
4 OMEPRAZOLE MAGNESIUM 10
5 FLUTICASONE PROPIONATE 9
6 HYDROCHLOROTHIAZIDE 9
7 METHOTREXATE 9
8 METOPROLOL 9
9 METOPROLOL TARTRATE INJECTION 9
See all common drugs associated with CARCINOID TUMOUR OF THE GASTROINTESTINAL TRACT

CARCINOID TUMOUR OF THE GASTROINTESTINAL TRACT is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 OMEPRAZOLE 20MG 1 0.0009
1 ANAGRELIDE HYDROCHLORIDE 1 0.0009
2 OCTREOTIDE ACETATE 13 0.0004
3 TRIPTORELIN PAMOATE 1 0.0004
4 LUTETIUM LU 177 DOTATATE 2 0.0003
5 ELUXADOLINE 1 0.0003
6 CAPSAICIN 1 0.0003
7 FLUOCINOLONE ACETONIDE 1 0.0003
8 PHENAZOPYRIDINE 1 0.0003
9 ANTIHEMOPHILIC FACTOR (RECOMBINANT), FC FUSION PROTEIN 1 0.0003
See all drugs enriched for association with CARCINOID TUMOUR OF THE GASTROINTESTINAL TRACT

CARCINOID TUMOUR OF THE GASTROINTESTINAL TRACT is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Interleukin-5 Antagonist [EPC] 1 0.0015
1 mu-Opioid Receptor Agonist [EPC] 1 0.0003
2 Phosphodiesterase 3 Inhibitor [EPC] 1 0.0002
3 Somatostatin Analog [EPC] 1 0.0001
4 Provitamin D2 Compound [EPC] 4 0.0001
5 Non-Standardized Plant Allergenic Extract [EPC] 1 0.0001
6 Thiazide Diuretic [EPC] 10 0.0000
7 Bile Acid [EPC] 1 0.0000
8 Intestinal Lipase Inhibitor [EPC] 1 0.0000
9 Androgen [EPC] 1 0.0000
See all drug classes enriched for association with CARCINOID TUMOUR OF THE GASTROINTESTINAL TRACT